Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,966,774
+$2,009,957 QoQ
Shares Held
197,593
+4.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#85
of 1,603 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRANDES INVESTMENT PARTNERS, LP holds $1,062,449,068 across 8 Drug Manufacturers - General names. NVS ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRFS |
Grifols SA
|
37,816,285 | $267,739,296 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,910,947 | $245,556,688 | |
| 3 | PFE |
Pfizer Inc
|
7,634,806 | $183,846,126 | |
| 4 | SNY |
Sanofi
|
4,136,417 | $176,459,547 | |
| 5 | GSK |
GSK plc
|
1,483,198 | $77,749,239 | |
| 6 | JNJ |
Johnson & Johnson
|
276,623 | $70,253,942 | |
| 7 | NVS |
Novartis AG
This page
|
197,593 | $30,966,774 | |
| 8 | OGN |
Organon & Co.
|
729,502 | $9,877,456 |
All Filings in NVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,966,774 | 197,593 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $28,956,817 | 189,570 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $36,231,821 | 262,797 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $31,787,489 | 247,875 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $28,955,514 | 239,282 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $25,083,779 | 225,007 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $20,412,718 | 209,770 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $24,586,559 | 213,759 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $23,870,886 | 224,224 | Shares | Sole | 2024-08-19 | |
| 2024-03-31 | $20,693,158 | 213,927 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $17,546,869 | 173,783 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $11,820,546 | 116,047 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,691,154 | 185,226 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,447,892 | 189,651 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,688,389 | 18,611 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,089,124 | 198,515 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $18,178,175 | 215,050 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $21,675,653 | 247,016 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $19,651,534 | 224,666 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $19,811,368 | 242,252 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $21,516,398 | 235,822 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $18,700,459 | 218,770 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $13,183,465 | 139,611 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||